MannKind Corp
MNKD
#5943
Rank
A$1.71 B
Marketcap
A$5.57
Share price
-4.87%
Change (1 day)
-4.68%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2026 (TTM): -A$41.7 Million

According to MannKind Corp's latest financial reports the company's current earnings are A$0.36 Billion. In 2025 the company made an earning of A$2 Million a decrease over its 2024 earnings that were of A$43.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$41.7 Million-2182.11%
2025 A$2 M-95.39%
2024 A$43.43 M-394.09%
2023 -A$14.78 Million-88.13%
2022 -A$0.13 Billion8%
2021 -A$0.12 Billion40.84%
2020 -A$81.79 Million10.7%
2019 -A$73.88 Million-40.16%
2018 -A$0.13 Billion-26.04%
2017 -A$0.17 Billion-193.33%
2016 A$0.17 B-134.11%
2015 -A$0.53 Billion85.72%
2014 -A$0.29 Billion3.6%
2013 -A$0.28 Billion12.79%
2012 -A$0.25 Billion5.58%
2011 -A$0.23 Billion-5.72%
2010 -A$0.25 Billion-22.51%
2009 -A$0.32 Billion-27.37%
2008 -A$0.44 Billion3.36%
2007 -A$0.42 Billion27.18%
2006 -A$0.33 Billion101.63%
2005 -A$0.17 Billion50.46%
2004 -A$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$15.07 B-37,162.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$35.60 B-87,627.65%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
A$44.30 B-109,020.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.72 B-46,124.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$0.71 B-1,861.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-A$0.22 Billion 432.64%๐Ÿ‡บ๐Ÿ‡ธ USA